Labcorp outlines 5.4% midpoint revenue growth and 9% EPS target for 2026 while advancing specialty and AI initiatives
Source: SeekingAlpha
2026-02-17 16:16:25 ET
More on Labcorp Holdings
- Labcorp Holdings Inc. (LH) Q4 2025 Earnings Call Transcript
- Labcorp Holdings Inc. 2025 Q4 - Results - Earnings Call Presentation
- Labcorp Holdings Inc. (LH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Labcorp slips after Q4 revenue miss
- Labcorp Holdings reports mixed results; initiates FY26 outlook
Read the full article on Seeking Alpha
For further details see:
Labcorp outlines 5.4% midpoint revenue growth and 9% EPS target for 2026 while advancing specialty and AI initiatives
Laboratory Corporation of America Holdings
NASDAQ: LH
LH Trading
-1.28% G/L:
$265.89 Last:
149,640 Volume:
$265.60 Open:
LH Latest News
February 23, 2026 07:00:00 am
Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide
LH Stock Data
$23,563,496,000
82,071,000
N/A
505
N/A
Medical Diagnostics & Screening
Healthcare
US
Burlington
